Global Legal Chronicle: Nkarta’s $230 Million Common Stock Offering
May 5, 2022
O’Melveny & Myers LLP represented Nkarta, Inc. in its follow-on public offering of 15.33 million shares of common stock, resulting in gross proceeds of nearly US$230 million. San Francisco-based Nkarta is a biopharmaceutical company focused on the treatment of cancer.
Read the full article here.